Janssen Biotech, Inc. v. Celltrion Healthcare Co., Ltd
Janssen Biotech, Inc. v. Celltrion Healthcare Co., Ltd
Opinion
Case: 18-2321 Document: 81 Page: 1 Filed: 03/05/2020
NOTE: This disposition is nonprecedential.
United States Court of Appeals for the Federal Circuit ______________________ JANSSEN BIOTECH, INC., Plaintiff-Appellant v. CELLTRION HEALTHCARE CO., LTD., CELLTRION, INC., HOSPIRA, INC., Defendants-Cross-Appellants ______________________ 2018-2321, 2018-2350 ______________________ Appeals from the United States District Court for the District of Massachusetts in No. 1:17-cv-11008-MLW, Chief Judge Mark L. Wolf. ______________________ JUDGMENT ______________________ GREGORY DISKANT, Patterson Belknap Webb & Tyler LLP, New York, NY, argued for plaintiff-appellant. Also represented by ANDREW D. COHEN, ARON RUSSELL FISCHER, EUGENE M. GELERNTER.
JAMES F. HURST, Kirkland & Ellis LLP, Chicago, IL, ar- gued for defendants-cross-appellants. Also represented by BRYAN SCOTT HALES; WILLIAM H. BURGESS, JOHN C.
O'QUINN, Washington, DC.
Case: 18-2321 Document: 81 Page: 2 Filed: 03/05/2020
______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (WALLACH, TARANTO, and STOLL, Circuit Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
March 5, 2020 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court
Case-law data current through December 31, 2025. Source: CourtListener bulk data.